Education
About Us
Working with TipRanks
Follow Us
Caplin Point Laboratories Limited (IN:CAPLIPOINT)
:CAPLIPOINT
Total Valuation
Caplin Point Laboratories Limited has a market cap or net worth of ₹151.75B. The enterprise value is ₹143.58B.
Market Cap₹151.75B
Enterprise Value₹143.58B
Share Statistics
Caplin Point Laboratories Limited has 76,011,696 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding76,011,696
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Caplin Point Laboratories Limited’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 15.83%.
Return on Equity (ROE)0.19
Return on Assets (ROA)0.17
Return on Invested Capital (ROIC)15.83%
Return on Capital Employed (ROCE)0.20
Revenue Per Employee5.69M
Profits Per Employee1.57M
Employee Count3,406
Asset Turnover0.60
Inventory Turnover2.29
Valuation Ratios
The current PE Ratio of Caplin Point Laboratories Limited is 26.9. Caplin Point Laboratories Limited’s PEG ratio is 1.58.
PE Ratio26.9
PS Ratio7.79
PB Ratio5.30
Price to Fair Value5.30
Price to FCF62.69
Price to Operating Cash Flow0.00
PEG Ratio1.58
Income Statement
In the last 12 months, Caplin Point Laboratories Limited had revenue of 19.40B and earned 5.36B in profits. Earnings per share was 70.57.
Revenue19.40B
Gross Profit11.38B
Operating Income8.83B
Pretax Income6.77B
Net Income5.36B
EBITDA6.49B
Earnings Per Share (EPS)70.57
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Caplin Point Laboratories Limited pays an annual dividend of ₹3, resulting in a dividend yield of 0.3%
Dividend Per Share₹3
Dividend Yield0.3%
Payout Ratio8.06%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.32
52-Week Price Change6.41%
50-Day Moving Average2.13K
200-Day Moving Average2.09K
Relative Strength Index (RSI)38.60
Average Volume (3m)6.71K
Important Dates
Caplin Point Laboratories Limited upcoming earnings date is Nov 6, 2025, TBA (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend DateSep 12, 2025
Financial Position
Caplin Point Laboratories Limited as a current ratio of 6.97, with Debt / Equity ratio of 0.00%
Current Ratio6.97
Quick Ratio5.87
Debt to Market Cap<0.01
Net Debt to EBITDA-0.91
Interest Coverage Ratio942.66
Taxes
In the past 12 months, Caplin Point Laboratories Limited has paid 1.36B in taxes.
Income Tax1.36B
Effective Tax Rate0.20
Enterprise Valuation
Caplin Point Laboratories Limited EV to EBITDA ratio is 22.43, with an EV/FCF ratio of 60.25.
EV to Sales7.49
EV to EBITDA22.43
EV to Free Cash Flow60.25
EV to Operating Cash Flow33.56
Balance Sheet
Caplin Point Laboratories Limited has ₹9.03B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹9.03B billion.
Cash & Marketable Securities₹9.03B
Total Debt₹0.00
Net Cash₹9.03B
Net Cash Per Share₹118.76
Tangible Book Value Per Share₹375.68
Margins
Gross margin is 60.75%, with operating margin of 29.68%, and net profit margin of 27.68%.
Gross Margin60.75%
Operating Margin29.68%
Pretax Margin34.93%
Net Profit Margin27.68%
EBITDA Margin33.39%
EBIT Margin29.99%
Analyst Forecast
The average price target for Caplin Point Laboratories Limited is ₹2,231.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target₹2,231.00
Price Target Upside10.20% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast13.14%
EPS Growth Forecast18.22%